AU4940801A - Antiprogestins with partial agonist activity - Google Patents

Antiprogestins with partial agonist activity

Info

Publication number
AU4940801A
AU4940801A AU4940801A AU4940801A AU4940801A AU 4940801 A AU4940801 A AU 4940801A AU 4940801 A AU4940801 A AU 4940801A AU 4940801 A AU4940801 A AU 4940801A AU 4940801 A AU4940801 A AU 4940801A
Authority
AU
Australia
Prior art keywords
antiprogestins
agonist activity
partial agonist
partial
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4940801A
Inventor
S Stoney Simons Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU4940801A publication Critical patent/AU4940801A/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
AU4940801A 2000-03-24 2001-03-23 Antiprogestins with partial agonist activity Pending AU4940801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19203900P 2000-03-24 2000-03-24
PCT/US2001/009395 WO2001072293A2 (en) 2000-03-24 2001-03-23 Antiprogestins with partial agonist activity

Publications (1)

Publication Number Publication Date
AU4940801A true AU4940801A (en) 2001-10-08

Family

ID=22707977

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4940801A Pending AU4940801A (en) 2000-03-24 2001-03-23 Antiprogestins with partial agonist activity
AU2001249408A Ceased AU2001249408B2 (en) 2000-03-24 2001-03-23 Antiprogestins with partial agonist activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001249408A Ceased AU2001249408B2 (en) 2000-03-24 2001-03-23 Antiprogestins with partial agonist activity

Country Status (5)

Country Link
EP (1) EP1274409A2 (en)
JP (1) JP2003528137A (en)
AU (2) AU4940801A (en)
CA (1) CA2404172A1 (en)
WO (1) WO2001072293A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008124145A1 (en) * 2007-04-05 2008-10-16 Government Of The U.S.A., As Represented By The Secretary, Department Of Health And Human Services Steroid compounds, compositions, and methods of treatment
JP7361397B2 (en) * 2017-11-03 2023-10-16 インサイチュジェン・リミテッド Test kits and assays

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3375261A (en) * 1966-07-08 1968-03-26 Merck & Co Inc Ring a unsaturated-20-oxo-11, 17-bis-oxygenated 16-methyl-steroids of the pregnane seies
US3775539A (en) * 1972-04-10 1973-11-27 Ciba Geigy Corp Methods and compositions for preventing retention of placenta following induced parturition in cattle
US3966927A (en) * 1974-12-16 1976-06-29 Binninger Clarence E Methods for inducing parturition in cattle with certain intravenously-injected synthetic glucocorticoids
DE3438994A1 (en) * 1984-10-22 1986-04-24 Schering AG, Berlin und Bergkamen, 1000 Berlin ANTIGESTAGENE, GLUCOCORTICOIDS AND PROSTAGLANDINE FOR THE INTRODUCTION OF BIRTH OR FOR THE ABORT OF PREGNANCY

Also Published As

Publication number Publication date
WO2001072293A3 (en) 2002-06-27
CA2404172A1 (en) 2001-10-04
AU2001249408B2 (en) 2006-03-09
EP1274409A2 (en) 2003-01-15
JP2003528137A (en) 2003-09-24
WO2001072293A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
EP1223095A4 (en) Body structure
TW454886U (en) Pivot structure
GB0002847D0 (en) Ampligier arrangement
HK1043931A1 (en) Electrode structure
AU8420301A (en) Use
IL147269A0 (en) FVIIa ANTAGONISTS
GB0025788D0 (en) Use
IL154364A0 (en) Arylalkane-sulfonamides having endothelin-antagonist activity
AU8439201A (en) Bis-heterocyclic compounds with antitumour and chemosensitising activity
AU4940801A (en) Antiprogestins with partial agonist activity
GB0005070D0 (en) Use
GB2370620B (en) Screw-on structure
HUP0301497A3 (en) 1,3-dioxolanes with antitussive activity
GB0029634D0 (en) Use
GB2373981B (en) Structure factor determinations
TW392566U (en) Improved saw stem structure
TW428699U (en) Lampstand structure
GB2395101B (en) Structure factor determinations
GB0222036D0 (en) Animal scarer
TW424521U (en) Skipping-ropes structure improvement
IL162750A (en) Cryoprobe
HU1988U (en) Feeder head with marking-unit
GB0007556D0 (en) Structure
TW417755U (en) Lampstand structure
GB0006860D0 (en) Antagonists